PAR2 regulates regeneration, transdifferentiation, and death

Area of Science:

• Cellular biology
• Regenerative medicine
• Endocrinology

Background:

• Cellular responses to injury are key to tissue regeneration.
• Previous work demonstrated islet cell transdifferentiation following pancreatic injury.
• The molecular mechanisms underlying this process remained largely unknown.

Purpose of the Study:

• To elucidate the molecular mechanisms of islet cell transdifferentiation.
• To investigate the role of protease-activated receptor-2 (PAR2) in tissue regeneration.
• To explore PAR2 as a potential therapeutic target for type 1 diabetes (T1D).

Main Methods:

• Inducing pancreatic injury (acinar cell damage + β-cell ablation) in mice.
• Modulating protease-activated receptor-2 (PAR2) activity.
• Analyzing gene expression and cell differentiation in pancreatic islets.
• Examining PAR2 expression in murine and human type 1 diabetes models.
• Assessing regeneration in liver and digit injury models in PAR2-deficient mice.

Main Results:

• Protease-activated receptor-2 (PAR2) activation is essential for islet cell transdifferentiation.
• PAR2 modulation alone can induce transdifferentiation, even without β-cells.
• PAR2 expression is altered in an islet cell-specific manner in type 1 diabetes.
• PAR2 influences β-cell apoptosis during pancreatitis.
• PAR2 deficiency impairs liver and digit regeneration following injury.

Conclusions:

• Protease-activated receptor-2 (PAR2) is a critical regulator of tissue regeneration.
• PAR2 represents a promising pharmacological target for enhancing regeneration in diseases like type 1 diabetes.
• Targeting PAR2 could offer novel therapeutic strategies for various regenerative medicine applications.